Astellas Pharma Inc. Site Map
 
Home > Press Room
   

Welcome to the Astellas Pharma US press room, where members of the news media will find the latest information about our company. This information includes clinical and business developments, company initiatives and achievements, media contact information, and other resources.

Download key resources for U.S. media professionals.

Download oncology-related fact sheets.

Learn more about Astellas in the U.S. and its products.

Latest News
January 31, 2012
MEDIVATION AND ASTELLAS ANNOUNCE POSITIVE RESULTS FROM THE PHASE 3 AFFIRM TRIAL OF MDV3100 IN PROSTATE CANCER PATIENTS WHO RECEIVED PRIOR CHEMOTHERAPY - PDF 76KB
January 06, 2012
ASTELLAS AND THERAVANCE ANNOUNCE TERMINATION OF LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR VIBATIV® (TELAVANCIN) FOR INJECTION - PDF 82KB
January 03, 2012
AVEO AND ASTELLAS ANNOUNCE TIVOZANIB SUCCESSFULLY DEMONSTRATED PROGRESSION-FREE SURVIVAL SUPERIORITY OVER SORAFENIB IN PATIENTS WITH ADVANCED RENAL CELL CANCER IN PHASE 3 TIVO-1 TRIAL - PDF 57KB
December 21, 2011
ZOGENIX AND ASTELLAS AGREE TO END CO-PROMOTION FOR SUMAVEL DOSEPRO EFFECTIVE MARCH 31, 2012 - PDF 59.6KB
December 01, 2011
ASTELLAS ADDS TWO KEY SENIOR EXECUTIVES AT AGENSYS, INC. - PDF 55KB
November 11, 2011
ASTELLAS SIGNS UNITED NATIONS GLOBAL COMPACT - PDF 80KB
Follow us on :    Follow us on Twitter

 
Copyright © 2005 - 2009 Astellas Pharma US, Inc. Site Map  Privacy Policy  Legal Disclaimer  Contact Us